๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Completion of adjuvant radiation therapy among women with breast cancer

โœ Scribed by Tomasz P. Srokowski; Shenying Fang; Zhigang Duan; Thomas A. Buchholz; Gabriel N. Hortobagyi; James S. Goodwin; Sharon H. Giordano


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
98 KB
Volume
113
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

BACKGROUND.

Optimal treatment for breast cancer often involves lengthy multimodality care including 5 to 6 weeks of radiotherapy, but few studies have evaluated adherence to radiotherapy outside the context of a therapeutic clinical trial.

METHODS.

Using a SEERโ€Medicare database, the authors identified women age 66 years or older with Stage I to III breast cancer diagnosed between 1992 and 2002. They evaluated rates of completion of radiotherapy, defined as a minimum of 25 sessions. Multivariate logistic regression analyses were performed to determine factors associated with completion of radiotherapy, and Cox multivariate models were used to determine the impact of radiotherapy completion on local recurrence.

RESULTS.

Some 24,510 patients were included in the study. Eightyโ€seven percent of patients completed 25 or more radiotherapy sessions. In multivariate logistic regression models, mastectomy (HR 1.26, 95% CI 1.10โ€1.43), hospitalization during treatment (2.87, 2.49โ€3.31), earlier year of diagnosis, and black race (1.36, 1.14โ€1.63) were associated with increased risk of nonโ€completion of radiotherapy. Among 21,269 patients treated with breast conservation, incomplete radiotherapy was associated with higher risk of local recurrence. A total of 98.7% of patients who did not complete radiation therapy were free of recurrence at 5 years vs. 97.5% of patients who completed radiation therapy (HR 1.46, CI 1.09โ€1.95).

CONCLUSION.

This study demonstrates relatively high rates of completion of radiation therapy among a population of older woman with breast cancer. However, those who did not complete a full course of radiotherapy had small but statistically significant higher risk of breast cancer recurrence. Future efforts should focus on intervening with women at high risk of not receiving adjuvant radiotherapy and increasing rates of radiotherapy completion. Cancer 2008. ยฉ 2008 American Cancer Society.


๐Ÿ“œ SIMILAR VOLUMES


Risk of second cancer among women with b
โœ Lene Mellemkjรฆr; Sรธren Friis; Jรธrgen H. Olsen; Ghislaine Scรฉlo; Kari Hemminki; E ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 111 KB ๐Ÿ‘ 2 views

## Abstract A large number of women survive a diagnosis of breast cancer. Knowledge of their risk of developing a new primary cancer is important not only in relation to potential side effects of their cancer treatment, but also in relation to the possibility of shared etiology with other types of

Risk of early recurrence among postmenop
โœ Hagen Kennecke; Heather McArthur; Ivo A. Olivotto; Caroline Speers; Chris Bajdik ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 162 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)โ€positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi